FeedForward - Where entrepreneurs intersect with industry
“Getting the right people in the room for each company’s specific needs for our FeedForward sessions is a Larta trademark,” remarked Judy Hsieh, Programs Director of Larta Institute. FeedForward™ sessions are closed-door, invitation-only workshops Larta has designed and managed for participating NIH-CAP (Commercialization Accelerator Program) companies to pitch their 18-month strategic plans to senior stakeholders, investors and other representatives in the medical and healthcare community. The two-hour, roundtable sessions allow for a deep dive into each component of the company’s Commercialization Roadmap.
“Our FeedForward™ sessions target the heart of Larta’s network-centric methodology. Not only do they receive constructive and candid advice from professionals in the industry, but the intimate setting enables each entrepreneur to connect with industry and other experts in a meaningful way beyond the sessions,” explains Rohit Shukla, CEO and Founder of Larta Institute.
For 11 years, Larta Institute has been organizing FeedForward™ sessions for companies in Larta’s NIH-CAP. Last month, we hosted sessions in Washington D.C. and U.C. Irvine, where 49 Bio Science companies received feedback from nearly 80 industry and domain experts, including representatives from GE, Siemens, John Hopkins University and TEDCO.
Key talking points are tailored to each company’s need, but also cover common ground such as the best target market, access to capital, product pricing and possible commercial exits.
FeedForward™ sessions are an opportunity to expand a startup company’s network, and understanding their next steps. The event has also evolved into a premier discovery ground for Larta’s network of industry leaders and experts, giving them the opportunity to interact directly with some of the most innovative NIH-funded life sciences companies in the U.S. today.
“I am very grateful to have been given the opportunity to serve as a mentor at Larta Institute’s NIH-CAP FeedForward sessions at our Washington D.C. session,” remarked Jim Sergi, President of CSSi LifeSciences, who joined our ranks of domain experts. His experience in the commercial launch of over 400 drugs and biologics joined the others around the table for several company presentations and discussions.
“It was a pleasure to be able to provide entrepreneurial firms withuseful tools and resources necessary to meet their key development and commercialization goals. It is my hope that the participants I interacted with walked away with real world, pragmatic advice and solutions in which they can implement immediately to dramatically increase their business model and successfully transition their innovations into the marketplace," continued Jim.